UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities and Exchange Act of 1934
(Amendment No. _____)*
LEUKOSITE, INC.
(Name of Issuer)
Common Stock, $0.01 par value
(Title of Class of Securities)
52728R 10 2
(CUSIP Number)
Check the following box if a fee is being paid with this statement [ ].
(A fee is not required only if the filing person:
(1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7).
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
Page 1 of 3 Pages
SCHEDULE 13G
CUSIP No. 52728R 10 2 Page 2 of 3 Pages
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
WARNER-LAMBERT COMPANY
22-1598912
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [
] (b) [ ]
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING
PERSON WITH
5 SOLE VOTING POWER
618,466
6 SHARED VOTING POWER
- -0-
7 SOLE DISPOSITIVE POWER
618,466
8 SHARED DISPOSITIVE POWER
- -0-
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING PERSON
618,466
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
EXCLUDES CERTAIN SHARES*
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
6.5%
12 TYPE OF REPORTING PERSON*
CO
Page 2 of 3 Pages
Item 1(a) Name of Issuer: LeukoSite, Inc.
Item 1(b) Address of Issuer's Principal Executive Offices:
215 First Street
Cambridge, MA 02142
Item 2(a) Name of Person Filing: Warner-Lambert Company
Item 2(b) Address of Principal Business Office:
201 Tabor Road
Morris Plains, New Jersey 07950
Item 2(c) Citizenship: Delaware
Item 2(d) Title of Class of Securities: Common
Item 2(e) CUSIP Number: 52728R 10 2
Item 3 The person filing is: N/A
Item 4 Ownership
(a) Amount Beneficially Owned: 618,466
(b) Percent of Class: 6.5%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 618,466
(ii) shared power to vote or to direct the vote: N/A
(iii) sole power to dispose or to direct the disposition of: 618,466
(iv) shared power to dispose or to direct the disposition of: N/A
Item 5 Ownership of Five Percent or Less of a Class: N/A
Item 6 Ownership of More than Five Percent on Behalf of Another Person:
N/A
Item 7 Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on By the Parent Holding Company: N/A
Item 8 Identification and Classification of Members of the Group: N/A
Item 9 Notice of Dissolution of Group: N/A
Item 10 Certification
By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above were acquired in the ordinary course of
business and were not acquired for the purpose of and do not have the effect of
changing or influencing the control of the issuer of such securities and were
not acquired in connection with or as a participant in any transaction having
such purposes or effect.
Signature
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: February 5, 1998
Signature: Rae Paltiel
Name/Title: Secretary
Page 3 of 3 Pages
